Department of Cardiology, Hillel Yaffe Medical Centre, Hadera, Israel; Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, UK.
Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, UK.
Int J Cardiol. 2022 Sep 15;363:210-217. doi: 10.1016/j.ijcard.2022.06.053. Epub 2022 Jun 22.
there is limited data on Emergency department (ED) cardiovascular disease (CVD) presentations and outcomes amongst cancer patients.
The present study aimed to describe the clinical characteristics, prevalence, and clinical outcomes of the most common cardiovascular ED admissions in patients with cancer.
All ED encounters with a primary CVD diagnosis from the US Nationwide Emergency Department Sample between January 2016 to December 2018 were stratified by cancer type as well as metastatic status. Multivariable logistic regression was performed to determine the adjusted odds ratios of in-hospital mortality in different groups.
From a total of 20,737,247 ED encounters with a primary CVD diagnosis, cancer was present in 3.4%. In patients with cancer the most common CVDs were DVT/PE (20%), hypertensive heart or kidney disease (14.7%), and AF/flutter (11.2%). The distribution of CVDs varied by cancer type, with AF/flutter most common in patients with lung cancer, AMI most common in patients with prostate cancer, heart failure most common in those with haematological malignancies, and patients with colorectal cancer having the greatest frequency of DVT/PE. Cancer status was independently associated with significantly higher risk of mortality in almost all CVD categories, consistent across all the cancer types, amongst which lung cancer patients had the highest risk of mortality across all CVD categories, except intracranial haemorrhage and hypertensive crisis.
Cardiovascular presentations to the ED varied by cancer subtype. Across all cancer subtypes, patients presenting with cardiovascular presentations carried a significantly increased risk of mortality compared to patients with no cancer.
癌症患者在急诊科(ED)的心血管疾病(CVD)表现和结局方面的数据有限。
本研究旨在描述癌症患者中最常见的心血管 ED 入院的临床特征、患病率和临床结局。
从 2016 年 1 月至 2018 年 12 月美国全国急诊科样本中,根据癌症类型和转移状态对所有 ED 就诊中存在主要 CVD 诊断的患者进行分层。采用多变量逻辑回归确定不同组别的院内死亡率的调整比值比。
在总共 20737247 例 ED 就诊中存在主要 CVD 诊断,癌症的患病率为 3.4%。在癌症患者中,最常见的 CVD 是 DVT/PE(20%)、高血压性心脏病或肾脏病(14.7%)和 AF/flutter(11.2%)。CVD 的分布因癌症类型而异,AF/flutter 在肺癌患者中最为常见,AMI 在前列腺癌患者中最为常见,心力衰竭在血液恶性肿瘤患者中最为常见,而结直肠癌患者 DVT/PE 的频率最高。癌症状况与几乎所有 CVD 类别中的死亡率显著升高独立相关,在所有癌症类型中均一致,其中肺癌患者在所有 CVD 类别中死亡率最高,除了颅内出血和高血压危象。
ED 心血管表现因癌症亚型而异。在所有癌症亚型中,与无癌症患者相比,心血管表现患者的死亡率显著升高。